Posts in press release
BIOQuébec and Maryland Tech Council Forge New Partnership to Advance Life Sciences

Laval, Québec / Frederick, Maryland – June 3, 2024 – BIOQuébec and the Maryland Tech Council (MTC) are delighted to announce a new Memorandum of Understanding (MOU) that will enhance cooperation and collaboration between life sciences sectors in Québec and Maryland. This partnership aims to foster mutual benefits and strengthen biopharma and biotech industries in both regions through shared information and opportunities.

Read More
BIOQUÉBEC AND MASSBIO RENEW THEIR MEMORANDUM OF COOPERATION AND COLLABORATION

Boston (Massachussetts), June 5, 2023 – At the 2023 BIO International Convention BIOQuébec and MassBio agreed to extend their existing memorandum of cooperation and collaboration for a 3-year period. This agreement, originally initiated in 2017 and renewed in 2019 at the same conference aims to facilitate business ties between their respective members and support the market development initiatives of both Québec and Massachusetts-based biotechnology sector companies.

Read More
Emmanuelle Toussaint, Executive Director of BIOQuébec, is Named One of Canada’s Most Inspiring Climate Leaders

BROMONT, Québec--(BUSINESS WIRE)--Emmanuelle Toussaint, Executive Director at BIOQuébec, Québec's largest biotechnology and life sciences network, has been named one of Canada’s most inspiring climate leaders in the ‘Women in Energy Transformation Series, an initiative by Women in Renewable Energy (WiRE), GLOBE Series and Pembina Institute. This award celebrates the most powerful women advancing Canada’s transition to a clean economy and identifies opportunities for more women to get involved.

Read More
Emmanuelle Toussaint Named Executive Director of BIOQuébec

BROMONT, Quebec--(BUSINESS WIRE)--BIOQuébec’s Board of Directors is proud to announce the appointment of Emmanuelle Toussaint as Executive Director, effective immediately. “We are very pleased to have Emmanuelle join us as Executive Director. She is tremendously influential in the business community, and her diverse professional experiences, paired with her leadership, energy, and passion, will be greatly appreciated by BIOQuébec and our partners,” indicated Frédéric Leduc, President of the Board. “BIOQuébec has been supporting its members for over thirty years, and I firmly believe that Emmanuelle will take BIOQuébec to new heights.”

Read More
Launches of new medicines in Canada declined consistently in recent years: new data

TORONTO, Ontario – June 13, 2022 – The launches of new medicines in Canada declined consistently and markedly in Canada over the past five years as ongoing changes to the pharmaceutical policy environment, including federal medicine pricing reforms (i.e., PMPRB reforms), have caused uncertainty about the Canadian market.

Read More
Quebec’s Life Sciences Strategy 2022-2025: A Promising Plan for BIOQuébec’s Members and Quebec’s Life Sciences Industry

BROMONT, Québec--(BUSINESS WIRE)--BIOQuébec welcomes the tabling of the 2022-2025 Quebec Life Sciences Strategy (QLSS) which will support - and above all, foster - the growth of Quebec’s life sciences ecosystem. The second version of the QLSS features three major objectives, five areas of focus, and ten promising measures for the industry.

Read More
Results of the Study on the Integration of Innovations – BIOQuébec Outlines a Framework for Action to Support Quebec’s Biopharmaceutical Innovations and Bolster Quebec’s Autonomy

Bromont (Québec), April 21 2022 — BIOQuébec is pleased to be releasing the results of a study on the integration of Quebec innovations into our healthcare system. It is also suggests courses of action to better support Quebec-based biopharmaceutical innovations during the entire process and strengthen Quebec’s autonomy.

Read More
BIOQuébec joins united call from life sciences, business and research leaders for a new approach by the federal government, so Canadians can get back to those “everyday moments”

BROMONT (Québec)- April 12, 2021 – BIOQuébec has added its voice to a national call by life sciences, research and business organizations across Canada for the federal government to work with them to create a better environment for the development and ommercialization of new vaccines, medicines and health technologies in Canada.

Read More
THE BIOTECHNOLOGY AND CRO INDUSTRY ISSUES SEVENTEEN FINANCING AND PUBLIC POLICY

A government ally in the project aiming to attract $4 billion in private investments to Quebec by 2022 and make the province one of the five North American life sciences hubs, BIOQuébec is releasing the results of a major study on financing and public and regulatory policies which clearly describes the situation and identifies avenues to help us achieve our shared goals.

Read More
BIOQUÉBEC AND TRIUMVIRATE ENVIRONMENTAL JOIN FORCES TO PROMOTE AND FACILITATE THE IMPLEMENTATION OF EFFECTIVE AND SUSTAINABLE LABORATORY PRACTICES

BIOQuébec and Triumvirate Environmental are pleased to announce they have finalized a collaboration agreement aiming to promote access for BIOQuébec members to products and services that will allow them to implement and maintain safe and sustainable laboratory practices.

Read More